Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    ADMA Biologics Inc.

    NASDAQ: ADMA · Real-Time Price · USD
    20.80
    -0.80 (-3.70%)
    At close: Jun 13, 2025, 3:59 PM
    21.50
    3.37%
    After-hours: Jun 13, 2025, 05:56 PM EDT

    ADMA Biologics Statistics

    Share Statistics

    ADMA Biologics has 238.73M shares outstanding. The number of shares has increased by 2.5% in one year.

    Shares Outstanding

    n/a
    		 238.73M

    Shares Change (YoY)

    n/a
    		 2.5%

    Shares Change (QoQ)

    n/a
    		 0.52%

    Owned by Institutions (%)

    n/a
    		 86.97%

    Shares Floating

    n/a
    		 230.4M

    Failed to Deliver (FTD) Shares

    n/a
    		 400

    FTD / Avg. Volume

    n/a
    		 0.01%

    Short Selling Information

    The latest short interest is 14.31M, so 6% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 14.31M

    Short % of Shares Out

    n/a
    		 6%

    Short % of Float

    n/a
    		 7.36%

    Short Ratio (days to cover)

    n/a
    		 6.28

    Valuation Ratios

    The PE ratio is 20.22 and the forward PE ratio is 22. ADMA Biologics's PEG ratio is -0.03.

    PE Ratio

    n/a
    		 20.22

    Forward PE

    n/a
    		 22

    PS Ratio

    n/a
    		 9.37

    Forward PS

    n/a
    		 4.5

    PB Ratio

    n/a
    		 11.45

    P/FCF Ratio

    n/a
    		 36.31

    PEG Ratio

    n/a
    		 -0.03
    Financial Ratio History

    Enterprise Valuation

    ADMA Biologics has an Enterprise Value (EV) of 3.98B.

    EV / Sales

    n/a
    		 9.32

    EV / EBITDA

    n/a
    		 26.92

    EV / EBIT

    n/a
    		 33.51

    EV / FCF

    n/a
    		 36.12

    Financial Position

    The company has a current ratio of 5.97, with a Debt / Equity ratio of 0.24.

    Current Ratio

    n/a
    		 5.97

    Quick Ratio

    n/a
    		 2.9

    Debt / Equity

    n/a
    		 0.24

    Debt / EBITDA

    n/a
    		 0.56

    Debt / FCF

    n/a
    		 0.75

    Interest Coverage

    n/a
    		 9.98

    Financial Efficiency

    Return on Equity is 56.64% and Return on Invested Capital is 50.31%.

    Return on Equity

    n/a
    		 56.64%

    Return on Assets

    n/a
    		 40.45%

    Return on Invested Capital

    n/a
    		 50.31%

    Revenue Per Employee

    n/a
    		 $622,560.58

    Profits Per Employee

    n/a
    		 $288,573.72

    Employee Count

    n/a
    		 685

    Asset Turnover

    n/a
    		 0.87

    Inventory Turnover

    n/a
    		 1.22

    Taxes

    Income Tax

    n/a
    		 -71.96M

    Effective Tax Rate

    n/a
    		 -57.24%

    Stock Price Statistics

    The stock price has increased by 95.67% in the last 52 weeks. The beta is 0.47, so ADMA Biologics's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.47

    52-Week Price Change

    n/a
    		 95.67%

    50-Day Moving Average

    n/a
    		 20.83

    200-Day Moving Average

    n/a
    		 18.8

    Relative Strength Index (RSI)

    n/a
    		 51.03

    Average Volume (20 Days)

    n/a
    		 3,494,226

    Income Statement

    In the last 12 months, ADMA Biologics had revenue of 426.45M and earned 197.67M in profits. Earnings per share was 0.85.

    Revenue

    n/a
    		 426.45M

    Gross Profit

    n/a
    		 219.55M

    Operating Income

    n/a
    		 138.98M

    Net Income

    n/a
    		 197.67M

    EBITDA

    n/a
    		 147.69M

    EBIT

    n/a
    		 139.64M

    Earnings Per Share (EPS)

    n/a
    		 0.85
    Full Income Statement

    Balance Sheet

    The company has 103.15M in cash and 82.12M in debt, giving a net cash position of 21.03M.

    Cash & Cash Equivalents

    n/a
    		 103.15M

    Total Debt

    n/a
    		 82.12M

    Net Cash

    n/a
    		 21.03M

    Retained Earnings

    n/a
    		 -308.58M

    Total Assets

    n/a
    		 510.57M

    Working Capital

    n/a
    		 298.32M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was 118.67M and capital expenditures -8.57M, giving a free cash flow of 110.1M.

    Operating Cash Flow

    n/a
    		 118.67M

    Capital Expenditures

    n/a
    		 -8.57M

    Free Cash Flow

    n/a
    		 110.1M

    FCF Per Share

    n/a
    		 0.47
    Full Cash Flow Statement

    Margins

    Gross margin is 51.48%, with operating and profit margins of 32.59% and 46.35%.

    Gross Margin

    n/a
    		 51.48%

    Operating Margin

    n/a
    		 32.59%

    Pretax Margin

    n/a
    		 29.48%

    Profit Margin

    n/a
    		 46.35%

    EBITDA Margin

    n/a
    		 34.63%

    EBIT Margin

    n/a
    		 32.59%

    FCF Margin

    n/a
    		 25.82%

    Dividends & Yields

    ADMA does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 4.95%

    FCF Yield

    n/a
    		 2.75%
    Dividend Details

    Analyst Forecast

    The average price target for ADMA is $26, which is 25% higher than the current price. The consensus rating is "Strong Buy".

    Price Target

    n/a
    		 $26

    Price Target Difference

    n/a
    		 25%

    Analyst Consensus

    n/a
    		 Strong Buy

    Analyst Count

    n/a
    		 4
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 5.35

    Graham Upside

    n/a
    		 -74.28%

    Scores

    Altman Z-Score

    n/a
    		 22.19

    Piotroski F-Score

    n/a
    		 7

    Add to Watchlist